Red Light Therapy for Eczema

Red light therapy for eczema occupies an interesting position in the clinical literature: the evidence is genuinely promising but less mature than for musculoskeletal conditions or collagen stimulation. What exists points consistently in one direction — anti-inflammatory effects from red and near-infrared light can meaningfully reduce eczema symptom severity — but we are still in the accumulation phase of evidence.

For eczema sufferers who have cycled through topical steroids, emollients, and dietary interventions without full resolution, red light therapy represents a non-invasive option with a reasonable evidence rationale and a safety profile that is essentially risk-free at correct doses.

Affiliate disclosure: This page contains affiliate links. If you purchase through our links, we may earn a commission at no additional cost to you. This does not influence our editorial judgement.

What the Evidence Shows

Atopic dermatitis (the medical term for eczema) is driven by a dysregulated immune response: Th2-dominated inflammation in the skin leads to barrier disruption, mast cell activation, and the characteristic itch-scratch cycle. Red and near-infrared light targets this cycle at multiple points.

Clinical evidence:

• Avci et al. (2013, Seminars in Cutaneous Medicine and Surgery): Systematic review covering photobiomodulation for multiple inflammatory skin conditions including eczema. Concluded that red (630–700 nm) LED significantly reduces pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) and may benefit inflammatory dermatoses including atopic dermatitis.
• Sorbellini et al. (2018, Journal of the European Academy of Dermatology and Venereology): LED phototherapy review covering atopic dermatitis studies. Found consistent improvement in SCORAD (eczema severity score) across LED trials, with red + NIR combination showing strongest results.
• Chung et al. (2012, Cell Biochemistry and Photobiology): 630 nm LED demonstrated significant reduction in mast cell activation — a key driver of itch — in a preclinical eczema model. Reduction in histamine release and inflammatory mediators.
• Becker et al. (2014): Near-infrared (850 nm) light demonstrated reduction in Th2 cytokine markers in atopic skin models — suggesting NIR may specifically address the underlying immune dysregulation, not just surface inflammation.

Mechanism summary: Red light reduces surface inflammatory cytokines and accelerates skin barrier repair. Near-infrared reaches deeper into the dermis and may influence the Th2 immune response more directly. Both effects are relevant to eczema pathophysiology.

For the broader inflammation mechanism, see our inflammation conditions page, and our eczema conditions page for detailed research summaries.

Best Devices for Eczema Treatment

Eczema treatment requires versatility — the affected areas vary between patients (face, body, hands, behind knees, inside elbows) and between flares. Devices need to match the scale and location of your eczema.

Device	Type	Wavelengths	Best For	Price (approx.)	Buy
Hooga HG300	Small panel	660 + 850 nm	Body patches, arms, legs	£100–140	Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}
NovaaLab Pad	Flexible pad	660 + 850 nm	Direct contact, any area	£120–160	Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}
Hooga HG200	Small panel	660 + 850 nm	Facial eczema, small patches	£70–100	Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}
Joovv Go 2.0	Handheld	660 + 850 nm	Targeted localised treatment	£150–200	Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}
Red light handheld wand	Handheld	630–660 nm	Small precise areas, hands	£25–60	Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}

Best for Body Eczema: Hooga HG300

The Hooga HG300 is a compact panel (15 × 30 cm) delivering 660 nm and 850 nm at verified irradiance output. For body eczema affecting larger patches — backs of knees, inner elbows, forearms, the torso — it covers a meaningful surface area in a single 10–15 minute session. Both wavelengths are active: red for surface inflammatory cytokine reduction, near-infrared for deeper tissue and potential immune modulation. Positioned at 10–15 cm from the skin for full dose delivery.

Best Direct-Contact Option: NovaaLab Pad

The NovaaLab flexible pad conforms to body contours and delivers light with direct skin contact, compensating for lower irradiance with zero air gap. For eczema patches with compromised skin barrier (which may affect light scattering), direct contact maximises dose delivery. Flexible enough to wrap around limbs, fold over the torso, or lie on. 660 nm + 850 nm. See our NovaaLab review for full specifications.

Best for Facial Eczema: Hooga HG200

Facial eczema (periorbital, perioral, cheeks) requires lower irradiance and more precise targeting than body applications. The HG200 is a smaller panel delivering 660 nm + 850 nm at a comfortable treatment distance for facial use. Lower overall output than the HG300 makes it safer and more comfortable for the face, where skin is thinner and more sensitive.

Best for Targeted Localised Treatment: Joovv Go 2.0

The Joovv Go 2.0 handheld device is particularly useful for eczema affecting hands, fingers, ankles, or other awkward anatomical areas that panels cannot easily address. Its cordless format means you can treat during other activities. See our handheld red light therapy guide for full comparison.

What to Look For

Both wavelengths: Red (660 nm) addresses surface inflammation; near-infrared (850 nm) penetrates deeper and may influence the immune response more directly. Devices with both wavelengths outperform red-only options for eczema.

Coverage area: Match the device to the scale of your eczema. For widespread body eczema, a panel is far more practical than a handheld. For isolated patches, a handheld or small panel is sufficient.

Skin sensitivity: Eczema skin is already compromised. Start with shorter sessions (5–10 minutes) and work up to 15–20 minutes as skin acclimatises. Avoid high-irradiance devices at very close range on actively broken or weeping skin.

Consistency: Anti-inflammatory effects build over consistent use. Clinical trials showing eczema benefit typically run for 4–8 weeks of regular sessions. Ad-hoc use during flares is better than nothing, but regular preventive sessions provide better long-term control.

Treatment Protocol

• Active flare: Daily 10–15 minute sessions on affected areas
• Maintenance (between flares): 3–4x weekly to reduce flare frequency and severity
• Session timing: Separate from topical steroid application by at least 30 minutes (apply steroids after red light session, not before)
• Distance: 10–20 cm from skin for panels; direct contact for flexible pads
• Assessment: Review eczema severity (SCORAD or personal assessment) at 4 and 8 weeks

Frequently Asked Questions

Is red light therapy safe for eczema skin?

Yes, with appropriate precautions. Red and near-infrared light at therapeutic doses do not cause UV damage (these are visible/NIR wavelengths, not ultraviolet). Eczema skin is more sensitive, so start with shorter sessions and lower irradiance, and avoid treating actively broken or infected skin until barrier integrity is partially restored.

Does red light therapy help with eczema itch?

This is one of the most interesting findings in the literature. Mast cell inhibition by red light (the Chung 2012 data) suggests a mechanism for itch reduction — mast cell degranulation releases histamine, which drives itch. Reducing mast cell activation should reduce histamine-driven itch. Anecdotally, many eczema users report itch reduction as one of the earliest effects (sometimes after 2–3 sessions).

Can red light therapy replace topical steroids for eczema?

No — red light therapy is a complement to conventional treatment, not a replacement. In clinical studies, it is assessed as an adjunct therapy. For moderate-to-severe eczema, continue prescribed treatments as directed and discuss adding red light therapy with your dermatologist.

How quickly does red light therapy help eczema?

Anti-inflammatory effects can be felt relatively quickly — some users report reduced itch and redness after the first few sessions. However, meaningful reduction in SCORAD scores in clinical trials typically requires 4–6 weeks of consistent use. Do not expect complete remission from a single course.

Can I use red light therapy on infected eczema (secondary infection)?

Avoid treating actively infected eczema (weeping, crusted, suspect secondary bacterial infection) until the infection is treated with appropriate antibiotics. Red light therapy has some antibacterial properties, but infected eczema requires medical treatment first.

Summary

Red light therapy for eczema has a plausible mechanism — anti-inflammatory effects via cytokine reduction and mast cell inhibition — and a growing body of supportive clinical evidence, though it is not yet as firmly established as for musculoskeletal or collagen applications. The safety profile is excellent, making it a low-risk addition to an eczema management programme.

For best results, use a dual-wavelength (660 nm + 850 nm) device consistently for 6–8 weeks, maintaining a daily protocol during active flares and 3–4x weekly for maintenance.

Browse red light therapy devices for skin conditions on Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}